Evidence map›Paper›PMID 37683579›Full record

SynthesisThe American journal of cardiology2023

Statins for Primary Prevention of Anthracycline Chemotherapy-Related Cardiac Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Siddharth Agarwal, Avirup Guha, Satyam Krishan, Abdul Rafeh Naqash, Daniel Addison, Eric H Yang, Ana Barac, Zain Ul Abideen Asad

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in The American journal of cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Siddharth AgarwalDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Avirup GuhaCardio-Oncology Program, Medical College of Georgia at Augusta University, Augusta, Georgia.
Satyam KrishanDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Abdul Rafeh NaqashDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Daniel AddisonCardio-Oncology Program, The Ohio State University, Columbus, Ohio.
Eric H YangUCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, California.
Ana BaracInova Schar Cancer Institute and Inova Heart and Vascular Institute, Fairfax, Virginia.
Zain Ul Abideen AsadDepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: drzainasad@gmail.com.

Funding

Early Detection and Mechanisms of Cancer Immunotherapy Associated CardiotoxicityK23HL155890 · NHLBI · OHIO STATE UNIVERSITY · PI ADDISON, DANIEL · 2021 to 2024
$663k
NHLBI NIH HHS K23 HL155890
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heart DiseasesHydroxymethylglutaryl-CoA Reductase InhibitorsAnthracyclinesAntibiotics, AntineoplasticCardiotoxicityHumansPrimary PreventionRandomized Controlled Trials as TopicAnthracyclinesAntibiotics, AntineoplasticHydroxymethylglutaryl-CoA Reductase Inhibitorsanthracyclinecardiotoxicitymeta-analysisstatin

Identifiers

PMID37683579
PMCPMC11345853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.